Skip to content
Our 2022 Year in Review is now live.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Research Review

      A monthly review of the most important psychedelics research.

      Review Archive

      News & Interviews

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Legalization & Decriminalization Tracker

      Mapping psychedelic drug policy reform across the United States

      Explore the Tracker
      New: Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

  • Post published:April 12, 2022
  • Post category:Press Release
Read more about the article Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

  • Post published:March 18, 2021
  • Post category:Press Release
Read more about the article Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

  • Post published:March 1, 2021
  • Post category:Press Release
Read more about the article Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

  • Post published:February 22, 2021
  • Post category:Press Release
Read more about the article Novamind Announces Marketing Services Agreements

Novamind Announces Marketing Services Agreements

  • Post published:January 26, 2021
  • Post category:Press Release
Read more about the article Novamind Expands Psychedelic Medicine Access in Utah

Novamind Expands Psychedelic Medicine Access in Utah

  • Post published:January 13, 2021
  • Post category:Press Release
Read more about the article Novamind Completes Reverse Takeover Transaction

Novamind Completes Reverse Takeover Transaction

  • Post published:December 24, 2020
  • Post category:Press Release
Read more about the article Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

  • Post published:December 22, 2020
  • Post category:Press Release
Read more about the article Novamind Closes Oversubscribed CAD$10 Million Private Placement

Novamind Closes Oversubscribed CAD$10 Million Private Placement

  • Post published:November 23, 2020
  • Post category:Press Release
Read more about the article Novamind and Hinterland Metals Enter into Amalgamation Agreement

Novamind and Hinterland Metals Enter into Amalgamation Agreement

  • Post published:November 17, 2020
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.